Dp1 is required for extra-embryonic development

Development

Volumn 130, Issue 7, 2003, Pages 1295-1305

  Kohn, Matthew J ^a   Bronson, Roderick T ^b   Harlow, Ed ^c   Dyson, Nicholas J ^c   Yamasaki, Lili ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b TUFTS UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

E2F transcription; Mouse; Trophectoderm

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL CYCLE S PHASE; CHORION; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; EMBRYO GROWTH; ENDOREDUPLICATION; GENE INACTIVATION; GENE LOSS; GENE REPRESSION; GIANT CELL; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; PHENOTYPE; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SURVIVAL; TROPHOBLAST; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FETAL DEATH; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; GENES, LETHAL; MICE; MICE, KNOCKOUT; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0037383818     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.00355     Document Type: Review

References (52)

1. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L. and Vousden, K. H. (1998). p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
2. Bosco, G., Du, W. and Orr-Weaver, T. L. (2001). DNA replication control through interaction of E2F-RB and the origin recognition complex. Nat. Cell Biol. 3, 289-295.
3. Brulet, P. and Jacob, F. (1982). Molecular cloning of a cDNA sequence encoding a trophectoderm-specific marker during mouse blastocyst formation. Proc. Natl. Acad. Sci. USA 79, 2328-2332.
4. Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M., van der Valk, M., Hooper, M. L., Berns, A. and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
5. Cloud, J. E., Rogers, C., Reza, T. L., Ziebold, U., Stone, J. R., Picard, M. H., Caron, A. M., Bronson, R. T. and Lees, J. A. (2002). Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell. Biol. 22, 2663-2672.
6. Cobrinik, D., Lee, M. H., Hannon, G., Mulligan, G., Bronson, R. T., Dyson, N., Harlow, E., Beach, D., Weinberg, R. A. and Jacks, T. (1996). Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644.
7. Dannenberg, J. H., van Rossum, A., Schuijff, L. and te Riele, H. (2000). Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051-3064.
8. DeGregori, J., Leone, G., Miron, A., Jakoi, L. and Nevins, J. R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
9. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
10. Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H. and Greenberg, M. E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
11. Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Horner, J., DePinho, R. A. and Alt, F. W. (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404, 897-900.
12. Gaubatz, S., Lindeman, G. J., Ishida, S., Jakoi, L., Nevins, J. R., Livingston, D. M. and Rempel, R. E. (2000). E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell 6, 729-735.
13. Ginsberg, D. (2002). E2F1 pathways to apoptosis. FEBS Lett 529, 122.
14. Gopalkrishnan, R. V., Dolle, P., Mattei, M. G., la Thangue, N. B. and Kedinger, C. (1996). Genomic structure and developmental expression of the mouse cell cycle regulatory transcription factor DP1. Oncogene 13, 2671-2680.
15. Harrison, D. J., Hooper, M. L., Armstrong, J. F. and Clarke, A. R. (1995). Effects of heterozygosity for the Rb-1Δ19neo allele in the mouse. Oncogene 10, 1615-1620.
16. Heyer, B. S., MacAuley, A., Behrendtsen, O. and Werb, Z. (2000). Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14, 2072-2084.
17. Hogan, B., Beddington, R., Costantini, F. and Lacy, E. (1994). Manipulating the Mouse Embryo - A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
18. Hu, N., Gutsmann, A., Herbert, D. C., Bradley, A., Lee, W. H. and Lee, E. Y. (1994). Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-1027.
19. Humbert, P. O., Rogers, C., Ganiatsas, S., Landsberg, R. L., Trimarchi, J. M., Dandapani, S., Brugnara, C., Erdman, S., Schrenzel, M., Bronson, R. T. et al. (2000a). E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol. Cell 6, 281-291.
20. Humbert, P. O., Verona, R., Trimarchi, J. M., Rogers, C., Dandapani, S. and Lees, J. A. (2000b). E2f3 is critical for normal cellular proliferation. Genes Dev. 14, 690-703.
21. Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H. et al. (2000). Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648.
22. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A. and Weinberg, R. A. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
23. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T. and Weinberg, R. A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
24. Jones, S. N., Roe, A. E., Donehower, L. A. and Bradley, A. (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
25. Jooss, K., Lam, E. W., Bybee, A., Girling, R., Muller, R. and la Thangue, N. B. (1995). Proto-oncogenic properties of the DP family of proteins. Oncogene 10, 1529-1536.
26. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H. and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
27. Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E. and Jacks, T. (1996). Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632.
28. Lindeman, G. J., Dagnino, L., Gaubatz, S., Xu, Y., Bronson, R. T., Warren, H. B. and Livingston, D. M. (1998). A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev. 12, 1092-1098.
29. Melino, G., de Laurenzi, V. and Vousden, K. H. (2002). p73: Friend or foe in tumorigenesis. Nat. Rev. Cancer 2, 605-615.
30. Montes de Oca Luna, R., Wagner, D. S. and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
31. Muller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D. and Helin, K. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285.
32. Ormondroyd, E., de la Luna, S. and la Thangue, N. B. (1995). A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 11, 1437-1446.
33. Palmero, I. and Peters, G. (1996). Perturbation of cell cycle regulators in human cancer. Cancer Surv. 27, 351-367.
34. Peeper, D. S., Dannenberg, J. H., Douma, S., te Riele, H. and Bernards, R. (2001). Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat. Cell Biol. 3, 198-203.
35. Rempel, R. E., Saenz-Robles, M. T., Storms, R., Morham, S., Ishida, S., Engel, A., Jakoi, L., Melhem, M. F., Pipas, J. M., Smith, C. et al. (2000). Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol. Cell 6, 293-306.
36. Rogers, K. T., Higgins, P. D., Milla, M. M., Phillips, R. S. and Horowitz, J. M. (1996). DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc. Natl. Acad. Sci. USA 93, 7594-7599.
37. Royzman, I., Austin, R. J., Bosco, G., Bell, S. P. and Orr-Weaver, T. L. (1999). ORC localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP. Genes Dev. 13, 827-840.
38. Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E. and Jacks, T. (2000). Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14, 3037-3050.
39. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T. and Jacks, T. (1995). A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10, 175-180.
40. Sherr, C. J. (1996). Cancer cell cycles. Science 274, 1672-1677.
41. Stiewe, T. and Putzer, B. M. (2000). Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469.
42. Trimarchi, J. M. and Lees, J. A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3, 11-20.
43. Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L. and Jacks, T. (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304.
44. Wu, C. L., Classon, M., Dyson, N. and Harlow, E. (1996). Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol. Cell Biol. 16, 3698-3706.
45. Wu, C. L., Zukerberg, L. R., Ngwu, C., Harlow, E. and Lees, J. A. (1995). In vivo association of E2F and DP family proteins. Mol. Cell Biol. 15, 2536-2546.
46. Wu, L., Timmers, C., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P., Wright, F. A., Field, S. J. et al. (2001). The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414, 457-462.
47. Yamasaki, L. (1999). Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. Biochim. Biophys. Acta 1423, M9-M15.
48. +/- mice. Nat. Genet. 18, 360-364.
49. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N. J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
50. Zhang, Y. and Chellappan, S. (1995). Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 10, 2085-2093.
51. Zhu, J. W., Field, S. J., Gore, L., Thompson, M., Yang, H., Fujiwara, Y., Cardiff, R. D., Greenberg, M., Orkin, S. H. and DeGregori, J. (2001). E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol 21, 8547-8564.
52. Ziebold, U., Reza, T., Caron, A. and Lees, J. A. (2001). E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391.